Filip Dubovsky - Mar 1, 2024 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role
President, R&D
Signature
/s/ Mark J. Casey, Attorney-in Fact
Stock symbol
NVAX
Transactions as of
Mar 1, 2024
Transactions value $
$0
Form type
4
Date filed
3/26/2024, 07:00 PM
Previous filing
Dec 18, 2023
Next filing
Mar 11, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVAX Restricted Stock Units Award $0 +144K $0.00 144K Mar 1, 2024 Common Stock 144K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
F2 One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date.